Literature DB >> 11884450

A role for CCR9 in T lymphocyte development and migration.

Shoji Uehara1, Alexander Grinberg, Joshua M Farber, Paul E Love.   

Abstract

CCR9 mediates chemotaxis in response to CCL25/thymus-expressed chemokine and is selectively expressed on T cells in the thymus and small intestine. To investigate the role of CCR9 in T cell development, the CCR9 gene was disrupted by homologous recombination. B cell development, thymic alphabeta-T cell development, and thymocyte selection appeared unimpaired in adult CCR9-deficient (CCR9(-/-)) mice. However, competitive transplantation experiments revealed that bone marrow from CCR9(-/-) mice was less efficient at repopulating the thymus of lethally irradiated Rag-1(-/-) mice than bone marrow from littermate CCR9(+/+) mice. CCR9(-/-) mice had increased numbers of peripheral gammadelta-T cells but reduced numbers of gammadeltaTCR(+) and CD8alphabeta(+)alphabetaTCR(+) intraepithelial lymphocytes in the small intestine. Thus, CCR9 plays an important, although not indispensable, role in regulating the development and/or migration of both alphabeta(-) and gammadelta(-) T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884450     DOI: 10.4049/jimmunol.168.6.2811

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  116 in total

Review 1.  Intestinal attraction: CCL25 functions in effector lymphocyte recruitment to the small intestine.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Chemokine receptors and leukocyte trafficking in the mucosal immune system.

Authors:  Ifor R Williams
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Detailed analysis of gene expression during development of T cell lineages in the thymus.

Authors:  Nami McCarty; Mari L Shinohara; Linrong Lu; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-09       Impact factor: 11.205

4.  The thymus microenvironment in regulating thymocyte differentiation.

Authors:  Jacy Gameiro; Patrícia Nagib; Liana Verinaud
Journal:  Cell Adh Migr       Date:  2010-07-15       Impact factor: 3.405

5.  CXCR3 and alphaEbeta7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes.

Authors:  F Annunziato; L Cosmi; F Liotta; E Lazzeri; P Romagnani; R Angeli; L Lasagni; R Manetti; F Marra; C Gerard; I Petrai; P Dello Sbarba; F Tonelli; E Maggi; S Romagnani
Journal:  Gut       Date:  2005-12-20       Impact factor: 23.059

Review 6.  Chemokine control of lymphocyte trafficking: a general overview.

Authors:  Jens V Stein; César Nombela-Arrieta
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

7.  A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus.

Authors:  M Lucila Scimone; Iannis Aifantis; Irina Apostolou; Harald von Boehmer; Ulrich H von Andrian
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

8.  Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry.

Authors:  Masatsugu Oh-Hora; Noriko Komatsu; Mojgan Pishyareh; Stefan Feske; Shohei Hori; Masaru Taniguchi; Anjana Rao; Hiroshi Takayanagi
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

9.  Opposing chemokine gradients control human thymocyte migration in situ.

Authors:  Joanna Halkias; Heather J Melichar; Kayleigh T Taylor; Jenny O Ross; Bonnie Yen; Samantha B Cooper; Astar Winoto; Ellen A Robey
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

10.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.